Preview

What Are Merck Stakeholders

Satisfactory Essays
Open Document
Open Document
438 Words
Grammar
Grammar
Plagiarism
Plagiarism
Writing
Writing
Score
Score
What Are Merck Stakeholders
CEO Ray Gilmartin
Merck's CEO Ray Gilmartin is a significant stakeholder in the company. Since a lot of Mercks' products patents will be expiring in the next few years Gilmartin put a big emphasis on investing into the companies research and development of new products. Gilmartin wanted this company to really focus on coming out with new products because their bottom line was going to take a hit in the next few years once the patent on their big money products runs out. Gilmartin found it an ideal time to invest in R&D while many of the other companies were investing in mergers which he saw as only a short term gain

Pfizer Company
Pfizer is a stakeholder in the Merck company simply because Pfizer is their major competitor. Pfizer is


You May Also Find These Documents Helpful

  • Satisfactory Essays

    Fi561 You Decide

    • 430 Words
    • 2 Pages

    I’m concerned about synergy and integration issues between our highly research-oriented development of pharmaceuticals here at Merck, and a prescription medicine marketing company like Medco. I am concerned that the cultures and operations of the two companies aren’t going to mix well, and that this deal would result in an expensive failure.…

    • 430 Words
    • 2 Pages
    Satisfactory Essays
  • Powerful Essays

    4. Lowe, Derek. “A Call For Merck To Cut R&D”. Seeking Alpha. August 21, 2013. Retrieved from http://seekingalpha.com/article/1649562-a-call-for-merck-to-cut-r-d?source=yahoo…

    • 1517 Words
    • 7 Pages
    Powerful Essays
  • Powerful Essays

    PharmaCARE is one of the world’s most successful pharmaceutical companies. It has a reputation for producing high quality products that saved millions of lives, and enhance the quality of millions of others. The company sponsors a program that offers free and discounted medication to low income customers. PharmaCARE has many stakeholders. Stakeholders being any one or group owning a significant percentage of a company shares, or a person or group not owning shares in an enterprise but affected by or having interest in its operation.(W.Dictionary) Having established the definition of a stakeholder, one can concur that PharmaCARE has plenty. When identifying the company’s stakeholders the first that come to mind are the investors, shareholders and employees, without these people the company would cease to exist. The secondary stakeholders are the customers, suppliers, communities, clinics, hospitals, and doctors’ offices, all of these groups have an interest or will be affected by the operations of PharmaCARE.…

    • 1672 Words
    • 5 Pages
    Powerful Essays
  • Powerful Essays

    We chose Johnson and Johnson as a company for our case analysis, and researches have shown that one of its main competitors is Pfizer, Inc.…

    • 1780 Words
    • 8 Pages
    Powerful Essays
  • Good Essays

    In 1999, Vioxx was approved by the Food and Drug administration to treat acute pain in arthritis patients. After 11 years with the company, Merck’s CEO, Raymond Gilmartin resigned the day that congressional investigators released documents stating that the company knew of Vioxx’s potentially harmful safety issues but continued to promote them. Gilmartin was said to be a “risky choice” when positioned as CEO because of his inexperience in the pharmaceutical industry, but was also honored because of his “highly ethical” work style. In the late 90s, Competition in the pharmaceutical industry was at its highest. Merck’s representatives in the sales department were told to keep quiet about their new drug, Vioxx’s potential cardiovascular side effects. Merck unethically increased their marketing of Vioxx even though they knew it was directly linked with increased risk of heart attack and stroke. Another main ethical issue presented in the case is that Merck underreported the number of deaths from Vioxx to the public. Although certain aspects of business can be challenging, withholding information from the general public is an unethical act that almost always leads to litigation. The information withheld was a clear violation of an individual’s basic rights.…

    • 718 Words
    • 3 Pages
    Good Essays
  • Good Essays

    Merck was renowned for its research labs which had decades of achievements, turning out one innovation after another, including drugs for tuberculosis, cholesterol, hypertension, and AIDS. In the early 2000s Merck spent around 3 billion in research; some felt that the company culture was shaped by its research agenda. The company was described as “intense, driven, loyal, scientifically brilliant, collegial, and arrogant”…

    • 2172 Words
    • 7 Pages
    Good Essays
  • Powerful Essays

    Strategy: Pfizer is the world’s number one pharmaceutical company. Its best-selling products include Lipitor, the world’s best- selling medicine, and eight of the top twenty-five medicines in the world. Acquisition of successful competitors such as Pharmacia and Warner Lambert has helped Pfizer to offer best-selling products and further differentiate itself from competitors. The acquisition of the latter company helped bring Lipitor under Pfizer’s control.…

    • 3675 Words
    • 15 Pages
    Powerful Essays
  • Satisfactory Essays

    Merck Executive Summary

    • 496 Words
    • 2 Pages

    Merck & Co., Inc., a leading pharmaceutical company, faces the threat of the patents of its most popular drugs expiring in 2002. The only way to counter the loss of sales from these drugs going off patent is to develop new drugs in order to refresh the company’s portfolio. LAB Pharmaceuticals, a small pharmaceutical company who specializes in the treatment of neurological disorders, has approached Merck with the opportunity to license Davanrik, a new drug with the potential to treat both depression and obesity. The drug is currently in pre-clinical development and would still need to pass a seven year and three phase testing process approved by the FDA. Under the licensing agreement, Merck would compensate LAB with an initial fee, milestone payments as the drug progresses through each phase, and royalty on sales. Merck must make a decision on whether or not to license the drug. If Merck does decide to license the drug, it must also decide how much the drug is worth.…

    • 496 Words
    • 2 Pages
    Satisfactory Essays
  • Best Essays

    The manufacturer like Merck-Medco, Lilly-PCS were concerned about losing access to their industries to PBM. PBMs are companies that administer drug benefit programs for employers and health insurance carriers. Their contracts are directly to managed care organizations, self-insured employers, insurance companies, Medicare, and almost all Federal and State government health benefits plans. To make the benefit plan more affordable PBM lowered their claims processing fees and also offered rebate retention. PBM also processed prescription drug claims, reviewed prescriptions, offered generic and branded medicines through mail services as well. Hence, due to PBM’s efficiency of delivering and processing the drug cut overall cost of health care benefits, the manufacturer industry got a big hit in their business. So, in the early 1990S, a large growth of managed care changed the health care industry that also had a heavy impact on…

    • 2738 Words
    • 11 Pages
    Best Essays
  • Best Essays

    Easyjet Marketing Analysis

    • 2108 Words
    • 9 Pages

    With the demand on transportation and advancements on technologies, airline industry became one of the fastest developing industries on the world. These developments, high leveled competitive market and the never-ending demand on faster transportation reduced the plane ticket prices. As a result the low-cost airlines (LCA) are flourished. Undoubtedly one of the key players in this progression was easyJet. They are widely known with their cheaper tickets however their marketing strategy had never been that simple. Their market segmentation, different researches on customer habits, satisfaction and their diversified services depending on these factors leaded easyJet’s marketing activities.…

    • 2108 Words
    • 9 Pages
    Best Essays
  • Good Essays

    Pfizer Inc. is a large pharmaceutical company that engages in the discovery of new technologies, the manufacture of prescription and "over the counter" (OTC) medicines, as well as the marketing of such products. It operates in three distinct segments that include Human Health, Consumer Healthcare, and Animal Health. For fiscal year 2004, the company generated approximately $53 billion in revenue that contributed to over $11 billion in net income. (Pfizer, 2004)…

    • 1018 Words
    • 5 Pages
    Good Essays
  • Better Essays

    PharmaCARE’s stakeholders are individuals and businesses that have an interest in the company’s day to day operations. Some of the stakeholders for PharmaCARE include employees, customers, investors, creditors, government agencies, and communities.…

    • 2008 Words
    • 9 Pages
    Better Essays
  • Powerful Essays

    Merck has a long history of working ethically to improve the health and well-being of the world population. The company started by Dr. Ernst Christian Friedrich Schering in Berlin in 1827 and opened for business in America in 1891 (Merck, 2010). Merck scientists are responsible for many important health care contributions, from the discovery of Vitamin B1, the first measles vaccine, antacids, to the first statins used to reduce cholesterol. Merck also takes pride in their commitment to animal health, revolutionizing veterinary science with the introduction of most pet medicines used today, such as antibiotics, and vaccines. Doctors worldwide await the annual publishing of the Merck Manual, providing valuable information on medicines and health conditions. Merging with Schering-Plough in 1971, Merck has evolved into the second largest pharmaceutical company in the world (Merck, 2010).…

    • 1847 Words
    • 8 Pages
    Powerful Essays
  • Satisfactory Essays

    Suppose that Merck decided to reduce its research and development expense by 50%. What would be the short-term implications? What would be the long-term implications? How do you think the stock market would react?…

    • 310 Words
    • 2 Pages
    Satisfactory Essays
  • Good Essays

    Merck Case

    • 587 Words
    • 4 Pages

    Merck had a 14% increase in sales between 1997 and 1998 and 22% increase in sales from 1998 – 1999, and a 13% annual increase in earnings over the same period. Merck’s business strategy consists of two parts: (1) developing and marketing new drugs through internal research, and (2) developing partnerships with smaller biotechnology companies. Since 1995, Merck had launched 15 new products that earned $5.9 billion on sales of $32.7 billion. Furthermore, Merck may agree to license new drugs from other firms and with its larger capital and greater assets, can assume the risk of submitting the drug through various regulatory approval phases. If the drug becomes profitable, Merck can earn significant cash flows while paying a royalty to the licensor. However, most important is the option that Merck has in deciding when to abandon or continue on this project (deferability or optionality). If Merck reaches a point when its expected NPV is negative, it can simply abandon the project. As a licensee, Merck can allow smaller biotechnology firms to focus on research and development. These smaller firms often have smaller budgets and are not financially or personnel equipped to handle the costly and long FDA approval process, and the subsequent marketing, distribution, and sales of new drugs. This task is better suited for a larger company, such as Merck, which has more resources and money.…

    • 587 Words
    • 4 Pages
    Good Essays